✦ LIBER ✦

P1141 SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV TREATMENT-EXPERIENCED PATIENTS AFTER TRIPLE THERAPY WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTING

✍ Scribed by Boeker, K.H.W.; Link, R.; Baumgarten, A.; Stoehr, A.; Heyne, R.; Roessle, M.; Schott, E.; Ullrich, R.; Erren, P.; Herold, C.; Schmidt, W.; Simon, K.-G.; Geissler, M.; Schiffelholz, W.; Alshuth, U.; Hueppe, D.; Mauss, S.

Book ID: 122326619
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 102 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61301-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1136 TRIPLE THERAPY WITH BOCEPREVIR PLU

P1136 TRIPLE THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTING: IS IT POSSIBLE TO ACHIEVE SVR RATES COMPARABLE TO PIVOTAL TRIALS?

✍ Buggisch, P.; Schober, A.; Bruch, H.R.; Antoni, C.; Loehr, H.; Herrmann, A.; Ste 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 117 KB

481 FOUR-WEEK THERAPY WITH PEGINTERFERON

481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ J.M. Vierling; E.J. Lawitz; F. Poordad; M.S. Sulkowski; M. Bourliere; M. Buti; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

P1146 VIROLOGICAL RESPONSE AND TOLERANCE

P1146 VIROLOGICAL RESPONSE AND TOLERANCE TO BOCEPREVIR OR TELAPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN TRIPLE THERAPY IN HIV–HCV CO-INFECTED PATIENTS: REAL-LIFE FINDINGS FROM THE PAN STUDY

✍ Baumgarten, A.; Holm, S.; Lutz, T.; Schranz, D.; Mauss, S.; Hillenbrand, H.; Mol 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Four-Week Therapy With Peginterferon Alf

Four-Week Therapy With Peginterferon Alfa-2B/Ribavirin Effectively Predicts Sustained Virologic Response in Treatment-NaïVE and Previous-Treatment-Failure Patients With HCV-1 Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Vierling, John M. ;Lawitz, Eric J. ;Poordad, Fred ;Sulkowski, Mark ;Bourliere, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Sustained Virologic Response and Bocepre

Sustained Virologic Response and Boceprevir Resistance-Associated Variants Observed in Patients Infected With HCV Genotype 1A/1b When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Brass, Clifford A. ;Barnard, Richard J. ;Howe, John A. ;Ogert, Robert A. ;Ralsto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 667 KB

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB